Travis E. Grotz, M.D.
Dr. Travis E. Grotz is a surgical oncologist at the Mayo Clinic in Rochester, Minnesota, specializing in minimally invasive approaches to gastrointestinal malignancies. His skills include robotic and laparoscopic cancer surgery for the treatment of various gastrointestinal cancers, including malignant peritoneal mesothelioma, as well as complex, extended resection of advanced soft tissue sarcomas.
His particular areas of clinical focus include gastric or stomach cancers, gastrointestinal stromal tumors, peritoneal mesothelioma, and the use of HIPEC surgery and other novel intraperitoneal treatments.[1]
Education and Career
Dr. Grotz earned a bachelor of arts degree in Psychology from Saint John’s University, graduating Magna Cum Laude. He then earned his medical degree at Creighton University School of Medicine. He completed his internship and residency as a Clinician Investigator at the Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine, then completed a fellowship as a Clinical Investigator/Immunology Research fellow at Mayo Clinic’s Department of Immunology. Dr. Grotz then completed a General Surgery Residency at the Mayo Clinic, followed by a fellowship in Complex General Surgical Oncology at the University of Texas MD Anderson Cancer. He also completed a Basic Science master’s degree in Clinical and Translational Science at the Mayo Graduate School, Mayo Clinic College of Medicine.[1]
Dr. Grotz also serves on the editorial board for the Annals of Surgical Oncology and is a guest editor on numerous other professional journals.
Professional Memberships
Dr. Grotz is a member of several professional associations, including:[1]
- American Society of Peritoneal Surface Malignancies
- Connective Tissue Oncology Society
- Alliance for Clinical Trials in Oncology
- Mesothelioma Applied Research Foundation
- Society of Surgical Oncology Peritoneal Surface Malignancy
- American College of Surgeons
- European Society of Surgical Oncology
- Multidisciplinary Gastroesophageal Cancer Tumor Board
- NCCN Malignant Peritoneal Mesothelioma Subcommittee
- National Comprehensive Cancer Network Panel Member
- Debbie’s Dream Foundation Gastric Cancer Fellowship, American Association for Cancer Research advisory board member
Research
Dr. Grotz’s research work focuses on evaluating diagnostic and treatment strategies to improve perioperative outcomes for patients undergoing sarcoma, peritoneal, and gastrointestinal surgeries with the goal of creating treatment sequencing strategies that maximize clinical response while minimizing patient complications.
His research is translated into his clinical care through the use of regional therapeutic approaches that combine direct surgical access to the tumor with the delivery of high concentrations of chemotherapy or radiation. This approach allows more directed and targeted treatment while minimizing systemic toxicities.[2]
He has served as a principal investigator and co-investigator on several clinical trials at the Mayo Clinic, and is currently involved in the following clinical trial:
- Trans-Pacific Multicenter Collaborative Study of Minimally Invasive Proximal Versus Total Gastrectomy for Proximal Gastric and Gastroesophageal Junction Cancers Start of enrollment: 2022 May 11
Recent publications include:[1]
- Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma. Fogliati, A., Zironda, A., Fiorentini, G., Adjei, S., Amro, A., Starlinger, P., Grotz, T., Warner, S., Smoot, R., Thiels, C., Kendrick, M., Cleary, S., Truty, M.>; Annals of Surgical Oncology. 2024 Feb 6
- Preoperative CA 19-9 Predicts Disease Progression in Colorectal Peritoneal Metastases Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy:… Fackche, N., Schmocker, R., Nudotor, R., Kubi, B., Cloyd, J., Grotz, T., Fournier, K., Dineen, S., Veerapong, J., Baumgartner, J., Clarke, C., Patel, S., Wilson, G., L…> ;Annals of Surgical Oncology. 2024 Feb 3
- Cytoreduction and Hyperthermic Intraperitoneal Paclitaxel and Cisplatin for Gastric Cancer with Peritoneal Metastasis. EeeLN Buckarma, Cornelius A Thiels, Zhaohui Jin, Travis E Grotz>; Annals of Surgical Oncology. 2024 Jan 1
